Skip to content
Antibiotic therapy for pneumonia episode artwork

Jul 15, 2014 10 min

Antibiotic therapy for pneumonia

from ADC podcast Hosted by BMJ Group

Community-acquired pneumonia (CAP) remains a force to reckon with, as it accounts for 1.1 million of all deaths in children less than 5 years of age globally, with disproportionately higher mortality occurring in the low and middle income-countries (LMICs) of Southeast Asia and Africa. Existing strategies to curb pneumonia-related morbidity and mortality have not effectively translated into meaningful control of pneumonia-related burden. A recent systematic review in ADC looks at trials conducted in LMICs to determine the most suitable antibiotic therapy for treating pneumonia (very severe, severe and non-severe). ADC global health commissioning editor Nick Brown talks to one of the authors, Rehana Salam, Division of Women and Child Health, The Aga Khan University, Karachi, Pakistan, to hear what they found. Read the paper: http://goo.gl/ZCw0Rr

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Antibiotic therapy for pneumonia

0:00 10:58

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of ADC podcast?

This episode is 10 minutes long.

When was this ADC podcast episode published?

This episode was published on July 15, 2014.

Can I download this ADC podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.